COPD Virtual Care Provider Wellinks Nabs $10M Series B First Close

Wellinks delivers virtual care management for chronic obstructive pulmonary disease (COPD) and other cardiopulmonary conditions, combining its Spire remote patient monitoring system with one-on-one clinical coaching. On August 4, 2026, the New Haven-based company announced a first close of its Series B round, securing $10 million. No lead investor was identified in the announcement, and the company did not specify how it intends to deploy the new capital. The funding arrives as Wellinks integrates predictive patient care capabilities gained through its acquisition of Spire Health, whose wearable tag technology captures continuous respiratory data. The company points to published research linking its Spire RPM System to a 45 percent reduction in COPD-related emergency room visits and a 65 percent drop in hospitalizations, with average annual savings of $11,300 per patient. Wellinks has also been deepening its value-based care footprint through partnerships with organizations such as CareAbout Health in New Jersey and Florida, and SoNE HEALTH in Connecticut, aiming to reach the large majority of COPD patients who currently lack access to pulmonary rehabilitation.